- Home
- DXCM vs WST Comparison
DXCM vs WST Comparison
Compare DXCM & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- WST
- Stock Information
- Founded
- DXCM 1999
- WST 1923
- Country
- DXCM United States
- WST United States
- Employees
- DXCM N/A
- WST N/A
- Industry
- DXCM Medical/Dental Instruments
- WST Medical/Dental Instruments
- Sector
- DXCM Health Care
- WST Health Care
- Exchange
- DXCM Nasdaq
- WST Nasdaq
- Market Cap
- DXCM 31.7B
- WST 18.9B
- IPO Year
- DXCM 2005
- WST N/A
- Fundamental
- Price
- DXCM $73.79
- WST $252.86
- Analyst Decision
- DXCM Strong Buy
- WST Strong Buy
- Analyst Count
- DXCM 19
- WST 8
- Target Price
- DXCM $99.89
- WST $329.43
- AVG Volume (30 Days)
- DXCM 4.5M
- WST 539.7K
- Earning Date
- DXCM 10-23-2025
- WST 10-23-2025
- Dividend Yield
- DXCM N/A
- WST 0.34%
- EPS Growth
- DXCM N/A
- WST N/A
- EPS
- DXCM 1.43
- WST 6.68
- Revenue
- DXCM $4,300,800,000.00
- WST $2,960,200,000.00
- Revenue This Year
- DXCM $17.03
- WST $6.28
- Revenue Next Year
- DXCM $15.59
- WST $6.02
- P/E Ratio
- DXCM $53.42
- WST $38.47
- Revenue Growth
- DXCM 9.30
- WST 2.90
- 52 Week Low
- DXCM $57.52
- WST $187.43
- 52 Week High
- DXCM $93.25
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- DXCM 37.50
- WST 53.58
- Support Level
- DXCM $75.39
- WST $254.35
- Resistance Level
- DXCM $77.84
- WST $262.23
- Average True Range (ATR)
- DXCM 2.44
- WST 5.86
- MACD
- DXCM -0.13
- WST -0.02
- Stochastic Oscillator
- DXCM 20.22
- WST 50.04
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.